Evidence map›Paper›PMID 35342410›Full record

ArticleJournal of oncology2022

Altered Expression of Survivin Variants

Dora Maria Cedano-Prieto, Fernando Bergez-Hernandez, Emir Adolfo Leal-Leon, Noemi Garcia-Magallanes, Fred Luque-Ortega, Veronica Picos-Cardenas, Edna Guerrero-Arambula, Bricia Gutierrez-Zepeda, Enrique Romo-Martinez, Eliakym Arambula-Meraz

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 59% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Dora Maria Cedano-PrietoLaboratorio de Genética y Biología Molecular, Facultad de Ciencias Químico Biológicas, Universidad Autónoma de Sinaloa, Culiacán 80010, Mexico.ORCID https://orcid.org/0000-0002-4204-2175
Fernando Bergez-HernandezPosgrado en Ciencias Biomédicas, Facultad de Ciencias Químico Biológicas, Universidad Autónoma de Sinaloa, Culiacán 80010, Mexico.ORCID https://orcid.org/0000-0002-8924-5738
Emir Adolfo Leal-LeonLaboratorio de Genética y Biología Molecular, Facultad de Ciencias Químico Biológicas, Universidad Autónoma de Sinaloa, Culiacán 80010, Mexico.ORCID https://orcid.org/0000-0001-9927-5917
Noemi Garcia-MagallanesLaboratorio de Biomedicina y Biología Molecular, Unidad Académica de Ingeniería en Biotecnología, Universidad Politécnica de Sinaloa, Mazatlán 82199, Mexico.ORCID https://orcid.org/0000-0001-8442-2873
Fred Luque-OrtegaLaboratorio de Ciencias Básicas, Facultad de Odontología, Universidad Autónoma de Sinaloa, Culiacán 80010, Mexico.ORCID https://orcid.org/0000-0002-6295-1958
Veronica Picos-CardenasLaboratorio de Genética, Facultad de Medicina, Universidad Autónoma de Sinaloa, Culiacán 80119, Mexico.
Edna Guerrero-ArambulaLaboratorio de Genética y Biología Molecular, Facultad de Ciencias Químico Biológicas, Universidad Autónoma de Sinaloa, Culiacán 80010, Mexico.
Bricia Gutierrez-ZepedaLaboratorio de Genética y Biología Molecular, Facultad de Ciencias Químico Biológicas, Universidad Autónoma de Sinaloa, Culiacán 80010, Mexico.
Enrique Romo-MartinezLaboratorio de Biomedicina y Biología Molecular, Unidad Académica de Ingeniería en Biotecnología, Universidad Politécnica de Sinaloa, Mazatlán 82199, Mexico.
Eliakym Arambula-MerazLaboratorio de Genética y Biología Molecular, Facultad de Ciencias Químico Biológicas, Universidad Autónoma de Sinaloa, Culiacán 80010, Mexico.ORCID https://orcid.org/0000-0003-1026-7430
Universidad Autónoma de Sinaloa · MXUniversidad Politécnica de Sinaloa

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer (BCa) is one of the leading causes of death in women with these types of malignancies. Early detection is pivotal to improve prognosis and reduce mortality. Several proteins and genes have been proposed as biomarkers for cancer; however, further studies are required before a molecule is accepted as a definitive biomarker. This study was aimed at investigating the expression of survivin variants

Identifiers

PMID35342410
PMCPMC8942702
OpenAlexW4221045656

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.